Guangdong Marubi Biotechnology Future Growth
Future criteria checks 5/6
Guangdong Marubi Biotechnology is forecast to grow earnings and revenue by 26.1% and 20.7% per annum respectively. EPS is expected to grow by 26.3% per annum. Return on equity is forecast to be 13.8% in 3 years.
Key information
26.1%
Earnings growth rate
26.3%
EPS growth rate
| Personal Products earnings growth | 21.0% |
| Revenue growth rate | 20.7% |
| Future return on equity | 13.8% |
| Analyst coverage | Good |
| Last updated | 06 May 2024 |
Recent future growth updates
Recent updates
Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,197 | 572 | 470 | 689 | 9 |
| 12/31/2025 | 3,524 | 464 | 376 | 561 | 13 |
| 12/31/2024 | 2,932 | 371 | 161 | 468 | 12 |
| 12/31/2023 | 2,322 | 286 | 221 | 375 | 14 |
| 9/30/2023 | 2,124 | 228 | -39 | 178 | N/A |
| 6/30/2023 | 1,974 | 188 | -96 | 113 | N/A |
| 3/31/2023 | 1,826 | 187 | -34 | 69 | N/A |
| 12/31/2022 | 1,732 | 174 | -65 | 48 | N/A |
| 9/30/2022 | 1,793 | 226 | -28 | 122 | N/A |
| 6/30/2022 | 1,730 | 176 | -83 | 48 | N/A |
| 3/31/2022 | 1,766 | 213 | -150 | -13 | N/A |
| 12/31/2021 | 1,787 | 248 | -128 | -7 | N/A |
| 9/30/2021 | 1,745 | 268 | -627 | 25 | N/A |
| 6/30/2021 | 1,825 | 385 | -519 | 253 | N/A |
| 3/31/2021 | 1,779 | 446 | -434 | 319 | N/A |
| 12/31/2020 | 1,745 | 464 | -387 | 362 | N/A |
| 9/30/2020 | 1,727 | 494 | 154 | 327 | N/A |
| 6/30/2020 | 1,780 | 527 | 309 | 339 | N/A |
| 3/31/2020 | 1,806 | 514 | 372 | 400 | N/A |
| 12/31/2019 | 1,801 | 515 | 459 | 466 | N/A |
| 9/30/2019 | 1,732 | 539 | 540 | 544 | N/A |
| 6/30/2019 | 1,662 | 477 | 557 | 562 | N/A |
| 3/31/2019 | 1,606 | 440 | 473 | 481 | N/A |
| 12/31/2018 | 1,576 | 415 | 505 | 517 | N/A |
| 12/31/2017 | 1,352 | 312 | 350 | 356 | N/A |
| 12/31/2016 | 1,208 | 232 | N/A | 213 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603983's forecast earnings growth (26.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 603983's earnings (26.1% per year) are forecast to grow faster than the CN market (24% per year).
High Growth Earnings: 603983's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 603983's revenue (20.7% per year) is forecast to grow faster than the CN market (14.5% per year).
High Growth Revenue: 603983's revenue (20.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603983's Return on Equity is forecast to be low in 3 years time (13.8%).